chrisvoncsefalvay/vaers-outcomes huggingface dataset:
positvie covid test; positvie covid test; This is a spontaneous report received from contactable reporter(s) (Physician). The reporter is the patient.  A 69-year-old male patient received BNT162b2 (BNT162B2), on 25Jan2021 as dose 1, single (Lot number: el9262), in right arm, on 19Feb2021 as dose 2, single (Lot number: en6201), in left arm and on 28Sep2021 as dose 3 (booster), single (Lot number: 30135ba) at the age of 67 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing). There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 22Jun2022, outcome "not recovered" and all described as "positvie covid test". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Unknown Results, notes: Indication: Treatment of COVID-19; (20Jun2022) Negative, notes: 2 days after completing Paxlovid; (22Jun2022) Positive, notes: 4 days after completing Paxlovid. Therapeutic measures were taken as a result of covid-19.  Clinical information: No allergies; Sender's Comments: Based on plausible dose -event relationship post vaccination and no other alternate explanation the causal role of BNT162B2 cannot be excluded for the reported LOE events
4/14/09 Infanrix given in RL. 10/29 parent returned to clinic and informed PVN that lump and bruising still present. 2 inch diameter of RL is yellow and blue discoloration with lump. Not red or hot to touch. 11-19-09 MD appt to evaluate - Instructed to watch for 3-6 ms.
Patient received Janssen vaccine and is 16 years old, Janssen is approved for ages 18 and up.
Pt recvd vax 17AUG92 & exp vomiting, diaphoresis & became pale following the vax; pt recovered on the same day; No further details were provided;
Upon administration of the shot, the expected stiffness and tender injection site I was told to expect for a few days,  has never gone away.  Instead,  the shoulder and bicep area of the injected,  right arm has maintained, and gradually increased in stiffness,  and increased pain during movement.
Patient awoke in middle of night after vaccination screaming/crying. Mom noticed child slightly off balance. Cough - croupy and nasal congestion started. 2 days after vaccination on 10-23-13, symptoms progressed, child falling and bumping into things. Child taken to E. R. - given DECADRON for croup/cough. Child seen in our office 10-25-13 for follow up - improving.
WITHIN 13 DAYS OF THE VACCINE PATIENT HAD HIS FIRST GRAND MAL SEIZURE (NO FEVER NOT FEBRILE) THERE IS NO HISTORY OF BRAIN TRAUMA OR FAMILY HISTORY OF SEIZURES.  HE WAS DIAGNOSED WITH A SEIZURE DISORDER AND HAS HAD 3 CLONIC TONIC SEIZURES WITHIN 6 WEEKS OF THE VACCINE
31JAN94 415PM pt recvd vax & 8PM both thighs sore to touch & swollen w/o redness, pt would not move legs; fretful; cried all noc; APAP given w/o relief; 1FEB94 t101.4 fretful, crying, refusing fluids; seen by MD; 2FEB94 t103.2, glassy-eye
8 days after vaccination I got a red swollen rash at the vaccination site. It does not hurt or itch.
Fully body migratory hives with severe itching.  Raised red bumps..  Has now lasted longer than 7 day before beginning to lessen.  Using hydrocortisone cream when severe.
Patient received bivalent COVID-19 Pfizer vaccination as the primary series. Patient was not previously vaccinated with monovalent vaccination. Patient advised that bivalent dose can be counted as a primary series dose and to continue with the recommended vaccination schedule (i.e., complete the primary series with a monovalent Pfizer-BioNTech vaccine, then administer a bivalent booster dose at least 2 months after completion of the primary series).
dry eyes; dry mouth; Mucous with a little blood; arm swelled up associated it with vaccine; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age (Age: 43 units not provided) received first dose of bnt162b2 (Solution injection; Batch/Lot number was not reported), via an unspecified route of administration on 15Apr2021 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date in 2021, patient experienced dry eyes, dry mouth, mucous with a little blood and arm swelled up so associated it with vaccine. Patient asked what happened if he did not take the second dose. He doesn't think he wanted to take the second dose. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
4/29/97-Rash all over body, cranky, decreased appetite and 3 days of fever. 2/12/99-Hypotonia throughout extremities and trunk. 7/1/99-Speech, hearing, in-toeing and poor eye contact concerns. 8/11/99-Autism and significant delay in speech. Pt had yellow eye discharge at 6 months of age with his 3rd polio (+) DTP (+) Hib.
patient received a dose of pfizer vaccine today when she had already received moderna on 5/5/21 at healthcare facility. I did inform the patient that she was receiving the pfizer vaccine but she said she didn't pay attention to that. I spoke with the patient and apologized for the error. I monitored her for 20 minutes post vaccine and spoke with employee at doctor's office to inform them of this. Patient apologized to us and seemed to be okay with the situation that occurred.
pt recvd vax; was crying for 10 hrs, not consolable; T 100 at home but no fever at hosp;no sign of swelling/redness;
Itching started in the mouth then spread to lips and face, then progressed to thickening of throat and difficulty swallowing.
Patient had body achs with an exposure to COVID-19. Resulted positive for COVID fully vaccinated.
My lips are numb. My left side is swollen  and numb. There's  a little  soreness in my left arm, but very sore in my left armpit (lymnodes) My skin feels itching today. I felt  a burning  sensation  and numbness last night.
This spontaneous case reported by a consumer, describes the occurrence of peripheral swelling (right swollen arm) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Mar 9, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 11, 2021, patient experienced peripheral swelling (right swollen arm). At the time of the report, peripheral swelling (right swollen arm): unresolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. Concomitant product use and treatment information not provided.
Headache, Myalgia, Diarrhea, NauseaVomiting, Fatigue Narrative:  1/1/21; ED visit for dehydration. Covid negative.
Soon after first vaccine, started getting bad pain in tooth, jaw and face / numbness in face. Saw dentist who said no infection present. Also some fingers and toes were going numb as well.  Eventually started having some short dizzy spells (split seconds). Pain went away after a couple of weeks. Numbness of fingers/toes and dizzy spells still recur.   Next period was 2 weeks late as well.
Pain in both sides of my neck muscles up the back of my head; Temporal headache; Nausea; Vomiting; Increased tiredness; Left arm soreness; This is a spontaneous report from a contactable nurse, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3183; Lot number also reported as FF8839) via an intramuscular route of administration in the left arm on 09Oct2021 at 12:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included DM type 2, palpitations, blood pressure (BP) issues, fibromyalgia, hypothyroid, seasonal allergies, gastroesophageal reflux disease (GERD), depression, anxiety and allergy to sulfa drugs (reported as sulf drugs). The patient was diagnosed with COVID-19, prior to the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received other medicines (unspecified) within two weeks prior to the COVID-19 vaccine. The patient previously took trimethobenzamide hydrochloride (TIGAN) and milnacipran hydrochloride (SAVELLA) for unknown indication on an unknown date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC8839) via an intramuscular route of administration in the left arm on 18Sep2021 at 13:15 (at the age of 54-years-old), as a single dose for COVID-19 immunisation. On 09Oct2021 at 20:30, the patient experienced pain in both sides of the neck muscles, up the back of the head, temporal headache, nausea, vomiting, increased tiredness and left arm soreness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pain in both sides of the neck muscles, up the back of the head, temporal headache, nausea, vomiting, increased tiredness and left arm soreness were resolving at the time of this report.
Patient reports cough,l fever and malaise after receiving the Pneumovax vaccine on 3/17/11. This was reported in a follow-up appt in September.
Information has been received from a medical assistant referring to a patient of unknown age and gender. Information about concurrent condition, concomitant medication and medical history was not provided. On 12-FEB-2019, the patient was vaccinated with improperly stored GARDASIL 9 (1 injection, via intramuscular, lot # reported as: N025428, expiration date: 19-JUN-2020; strength and anatomical location were not reported) for prophylaxis. No adverse effect was reported. The GARDASIL 9 was exposed to 0 degree Celsius for 45 minutes. There was no previous temperature excursion. The data logger was involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1902USA008818: US-009507513-1903USA006922: US-009507513-1903USA006923: US-009507513-1903USA006924: US-009507513-1903USA006925: US-009507513-1903USA006926: US-009507513-1903USA006927: US-009507513-1903USA006928: US-009507513-1903USA006929: US-009507513-1903USA006930: US-009507513-1903USA006931: US-009507513-1903USA006932: US-009507513-1903USA006933: US-009507513-1903USA006934: US-009507513-1903USA006935: US-009507513-1903USA006936: US-009507513-1903USA006937: US-009507513-1903USA006938: US-009507513-1903USA006939: US-009507513-1903USA006940: US-009507513-1903USA006941: US-009507513-1903USA006942: US-009507513-1903USA006943: US-009507513-1903USA006944: US-009507513-1903USA006945: US-009507513-1903USA006946: US-009507513-1903USA006947: US-009507513-1903USA006948: US-009507513-1903USA006950.
Hospital Course and Significant Findings: The patient is 74 years old and has a PMH significant for hypertension, hyperlipidemia, moderate obstructive sleep apnea not on CPAP, parkinsonism, anemia, hypothyroidism, rhabdomyolysis, hysterectomy & bilateral salpingo-oophorectomy & pelvic lymph node dissection 9/2020, endometrial cancer status post radiation, and ovarian tumor who was admitted to the hospital on 12/21/2022 after a fall and being down for 14 hours.  The patient complained of generalized weakness but had no major injuries.  The patient had a temperature of 100.1 and was diagnosed with COVID-19.  Chest x-ray was negative and she was not hypoxic.  However, the patient a CPK level of 8900.  The patient statin was held and the patient was volume expanded (cautiously given her COVID positive status).  The patient declined remdesivir.  The patient's CPK level steadily improved, was down to 928 by 12/26 and the IV fluids were discontinued.       The patient continued to have low-grade fevers through 12/23.  The patient never required supplemental oxygen..  The patient's date of COVID exposure was 12/18 and had onset of symptoms 12/19.  The test was positive 12/21.  The patient is fully vaccinated but not boosted.  The patient did not require steroids.  The patient is to isolate through 12/29.  The patient was on enoxaparin for DVT prophylaxis.   The patient's amlodipine and losartan were held and gradually and reintroduced.  The patient will resume her usual dose of losartan and amlodipine at the skilled nursing facility.  Hydrochlorothiazide remains on hold.   The patient was seen by physical therapy and daily PT was recommended.
Six days after MMR vaccine, my son woke up with swollen hands and genitals. He had a mild cough and during the day started breaking out in hives. Pediatrician started on Benadryl and Orapred. By evening, whole body covered in hives and face swollen tight. Fever 101 degrees and eyes swelled up and he started shaking. Admitted to ER with IV steroids, Benadryl, Pepcid. Follow up at home with Orapred, Benadryl, Zyrtec. Lasted about 4-5 days. Dx was unknown allergic reaction.
pt recvd vax; swelling of eyes & hands 24 hrs p/ vax;exam on 22feb96; mild induration rt thigh;
A report has been received from a Health Professional concerning a patient born on 09-Oct-2008, Male subject, who had been receiving Nasal FLUMIST QUADRIVALENT (intranasal). The patient's concurrent(s) included Asthma. FLUMIST QUADRIVALENT (intranasal) started on an unknown date. The physician's assistant reported that they administered FLUMIST QUADRIVALENT to a patient who had asthma on 01-Nov-2013. The outcome of the event of administration of FLUMIST QUADRIVALENT to patient with asthma is unknown. The report was considered to be non-serious by the reporter.
This spontaneous report as received from a pharmacist refers to a newborn female patient of unknown age. On 18-OCT-2012 17:11, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Shortly after receiving the mist H1N1 he felt dizzy, had headaches to come and go, and cold sweats. Keep home from school following day. Gave him ALEVE for headache. He was feeling better on day 2.
quite ill; lingering affects; felt like they had trouble breathing/Shortness of breath; They were not getting enough sleep; exhausted; This spontaneous case was reported by a patient family member or friend and describes the occurrence of ILLNESS (quite ill), IMMUNISATION REACTION (lingering affects), DYSPNOEA (felt like they had trouble breathing/Shortness of breath), HYPOSOMNIA (They were not getting enough sleep) and FATIGUE (exhausted) in a male patient of an unknown age who received mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (batch no. 3031278) for COVID-19 prophylaxis.     No Medical History information was reported.    On 05-Oct-2023, the patient received sixth dose of mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (unknown route) 1 dosage form. On 05-Oct-2023,  after starting mRNA-1273.815 (SPIKEVAX 2023-2024 PFS), the patient experienced ILLNESS (quite ill). In October 2023, the patient experienced IMMUNISATION REACTION (lingering affects), DYSPNOEA (felt like they had trouble breathing/Shortness of breath), HYPOSOMNIA (They were not getting enough sleep) and FATIGUE (exhausted). At the time of the report, ILLNESS (quite ill) and DYSPNOEA (felt like they had trouble breathing/Shortness of breath) was resolving and IMMUNISATION REACTION (lingering affects), HYPOSOMNIA (They were not getting enough sleep) and FATIGUE (exhausted) outcome was unknown.        For mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-745579 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-745579:Wife's case, 6th dose
Information has been received from an office registered nurse concerning a 19 year old who on 08-AUG-2007 was vaccinated with Gardasil.  On 08-AUG-2007, the patient fainted after the injection.  The patient fell from the exam table and sustained a lacerated forehead.  The patient recovered from the fainting.  Medical attention was sought and the patient was taken to a plastic surgeon's office to repair the laceration.  No other symptoms were reported.  Additional information has been requested.
p/vax pt exp swelling & redness w/streaks @ the inj site;pt exp cellulitis of the upper arm @ a site separate from the inj site;pt recovered from the cellulitis;pt recovered from redness @ inj site & swelling @ inj site;
This spontaneous report was received from a registered nurse and refers to an unspecified number of patients of unknown ages and genders. There was no information about the patients' pertinent medical history, concomitant medications, drug reactions or allergies provided. On unspecified dates, the patients were vaccinated with improperly stored PEDVAXHIB (lot # N000237 with the expiration date of 25-OCT-2019; dose number, exact dose and route of administration were not reported), for prophylaxis. No adverse effects were reported. The administered doses of vaccine experienced a temperature excursion of 51 Fahrenheit degrees for 15 minutes. Digital data logger was used to capture the temperature excursion. There were no previous temperature excursions reported. This was one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1708USA002664.
Patient started bleeding upon injection administration and then swelling occurred immediately. Cold compress was applied. Patient was followed for 24 hours and symptoms lessened.
This spontaneous report was received from a registered nurse regarding an unspecified patients of unknown age and gender, who were vaccinated since 03-JUN-2015 with an improperly stored (Oka/Merck) VARIVAX (lot number, expiration date, route, doses, dose number were not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Had 99.8 fever 2/16 to 2/18 with body pains and joint pains. My body  joint pains were amplified by 8 times the usual pain. Then around early April, the first episode of pain on my middle finger tip started.  It begins with a dull pain then develops into shooting pain that would last for about 2 minutes.  As the weeks passed, it became more frequent involving other fingers. Around May 2021 I felt the same shooting pain on my arm near the elbow first them in the wrist and fingers area. The pain severity is about 8-9 on a scale of 10. Painful.  On the left side of my body some of the muscles twitch but not painful.  Also, the back and joint pains have not subsided or returned to pre February intensity.
12/31/20: Fatigue, headaches 1/4/21: Swollen & painful lymph nodes  of left underarm, swelling & redness at injection site.
Vaccine was administered on a Friday night. Patient came in on Sunday and said she had a rash in 2 places on upper arm, a small knot, and arm was feverish. Patient went to her doctor on Monday, who said she was fine. Followed up with patient on 10/16/15 and she said it was all gone and she is fine.
patient said he developed a rash on the vaccinated arm 2 days following the vaccine, went to an urgent care clinic on 10/9/2020 where he was treated with antivirals and gabapentin
Patient got the Moderna booster (0.25 ml) on 1/17 and came in 1/19 describing that he had had a stroke. Patient did not go to the hospital, but said it has affected his memory. Maybe some right sided weakness, but patient mobile and able to stand for 10-15 minutes.
05/17 - Got the shot at 3:15 pm; 05/18 - had a slight headache and a sore arm; 05/19 - still had the headache and had vertigo, at 4:30 I had a sip of water and started throwing up, which continued nonstop for two hours. 05/20 - didn't sleep all last night because every muscle in my upper body was in such pain. I was still in pain in the afternoon. I literally could not move. 05/21 - small amount of pain but still somewhat dizzy. I stayed home and slept most of the day. 05/22 - I felt slightly better and was able to move without much pain. 05/23 - not in pain but exhausted.
1 dose: ? Hiccup                   ?  Hot flash for 2 days                  ?  Itching on right wrist and left calf 2 dose: ? Hiccups still                   ?swollen neck lymph glands                   ?Hot Flashes 3 days                   ?one day spot menstrual cycle/amenorrhea                    ?Plantars wart/face qart/ both hands wart                   ?Boil on inner thigh
pt recvd vax; devel hard lump (size of a quarter) & has not improved; no pain or palpitation;
pt recvd vax & broke out in a bumpy rash on arms; prescribed topical cream for itching; pt recvd dose 2 of Engerix-B w/o any problems;
Baby passed out as the shots where giving, she couldn't cry or grasp air, her limps looked very relaxed and her eyes were closing, ones she woke up she looked spaced out.
I had a headache that would not go away. The headache was on one side of my head. It was radiating to my cheekbones. I also had runny nose and watery eyes on one side of my face. It was only on my left side. I went to the doctor who classifies it as a cluster headache which I have never had before. The next morning it was gone completely. Since then, I have had headaches but none as bad as the first one.
have bad knee osteoarthritis; The initial case was missing the following minimum criteria: adverse event. Upon receipt of follow-up information on 30Oct2023, this case now contains all required information to be considered valid.  This is a spontaneous report received from a contactable reporter (Consumer or other non HCP) from medical information team. The reporter is the patient. A 76-year-old male patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13), as dose number unknown, single (Batch/Lot number: unknown) at the age of 68 years for immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Ppv23 (because it has been more than 5 years), when the patient was 65 years old, for Immunization. The following information was reported: OSTEOARTHRITIS (medically significant), outcome "unknown", described as "have bad knee osteoarthritis". Therapeutic measures were taken as a result of osteoarthritis. Additional information: the patient reported that he has bad knee osteoarthritis, every once in a blue moon he goes and get a cortisone shot directly into the knee. He added that he had PPV23 at 65, PCV13 at 68, because it has been more than 5 years, he may get Prevnar 20.  The information on the batch/lot number for pneumococcal 13-val conj vac (dipht crm197 protein) has been requested and will be submitted if and when received.
Started with a headache, fatigue, warm to the touch.  Flu like symptoms per mom.  Rash on the crook of her Right arm maculopapular with itching.
redness-heat-pain;swelling up to shoulder & down to elbow;rash-itching later; low grade fever, chills, malaise, aches;